2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis D Van Der Heijde, S Ramiro, R Landewé, X Baraliakos, F Van den Bosch, ... Annals of the rheumatic diseases 76 (6), 978-991, 2017 | 1823 | 2017 |
B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor … A Finckh, A Ciurea, L Brulhart, D Kyburz, B Möller, S Dehler, S Revaz, ... Arthritis & Rheumatism 56 (5), 1417-1423, 2007 | 316 | 2007 |
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort C Molnar, A Scherer, X Baraliakos, M de Hooge, R Micheroli, P Exer, ... Annals of the rheumatic diseases 77 (1), 63-69, 2018 | 263 | 2018 |
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections L Hunziker, M Recher, AJ Macpherson, A Ciurea, S Freigang, ... Nature immunology 4 (4), 343-349, 2003 | 262 | 2003 |
Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis SMD Pan, S Dehler, A Ciurea, HR Ziswiler, C Gabay, A Finckh Arthritis Care & Research: Official Journal of the American College of …, 2009 | 231 | 2009 |
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of … A Finckh, A Ciurea, L Brulhart, B Möller, UA Walker, D Courvoisier, ... Annals of the rheumatic diseases 69 (2), 387-393, 2010 | 194 | 2010 |
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort A Ciurea, A Scherer, P Exer, J Bernhard, J Dudler, B Beyeler, R Kissling, ... Arthritis & Rheumatism 65 (12), 3096-3106, 2013 | 192 | 2013 |
Delays in assessment of patients with rheumatoid arthritis: variations across Europe K Raza, R Stack, K Kumar, A Filer, J Detert, H Bastian, GR Burmester, ... Annals of the rheumatic diseases 70 (10), 1822-1825, 2011 | 192 | 2011 |
Viral persistence in vivo through selection of neutralizing antibody-escape variants A Ciurea, P Klenerman, L Hunziker, E Horvath, BM Senn, AF Ochsenbein, ... Proceedings of the National Academy of Sciences 97 (6), 2749-2754, 2000 | 172 | 2000 |
Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population‐based cohort study S Genevay, A Finckh, A Ciurea, AM Chamot, D Kyburz, C Gabay, ... Arthritis Care & Research 57 (4), 679-685, 2007 | 155 | 2007 |
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice A Ciurea, P Klenerman, L Hunziker, E Horvath, B Odermatt, ... Proceedings of the National Academy of Sciences 96 (21), 11964-11969, 1999 | 133 | 1999 |
Impairment of Cd4+ T Cell Responses during Chronic Virus Infection Prevents Neutralizing Antibody Responses against Virus Escape Mutants A Ciurea, L Hunziker, P Klenerman, H Hengartner, RM Zinkernagel The Journal of experimental medicine 193 (3), 297-306, 2001 | 128 | 2001 |
Neutralizing antiviral antibody responses RM Zinkernagel, A Lamarre, A Ciurea, L Hunziker, AF Ochsenbein, ... Academic Press 79, 1-53, 2001 | 116 | 2001 |
18F-Fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis K Strobel, DR Fischer, G Tamborrini, D Kyburz, KDM Stumpe, ... European journal of nuclear medicine and molecular imaging 37, 1760-1765, 2010 | 102 | 2010 |
Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitis K Niedermann, E Sidelnikov, C Muggli, H Dagfinrud, M Hermann, ... Arthritis care & research 65 (11), 1844-1852, 2013 | 96 | 2013 |
CD4+ T-cell–epitope escape mutant virus selected in vivo A Ciurea, L Hunziker, M Martinic, A Oxenius, H Hengartner, ... Nature medicine 7 (7), 795-800, 2001 | 92 | 2001 |
A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria AF Ochsenbein, U Karrer, P Klenerman, A Althage, A Ciurea, H Shen, ... Proceedings of the National Academy of Sciences 96 (16), 9293-9298, 1999 | 86 | 1999 |
Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design AF Ochsenbein, DD Pinschewer, B Odermatt, A Ciurea, H Hengartner, ... The Journal of Immunology 164 (12), 6296-6302, 2000 | 81 | 2000 |
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis R Micheroli, M Hebeisen, LM Wildi, P Exer, G Tamborrini, J Bernhard, ... Arthritis research & therapy 19, 1-8, 2017 | 78 | 2017 |
Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trial K Niedermann, RA de Bie, R Kubli, A Ciurea, C Steurer-Stey, PM Villiger, ... Patient education and counseling 82 (1), 42-48, 2011 | 71 | 2011 |